Skip to main content

Market Overview

Acadia Pharmaceuticals May Be Subject Of A Bidding War

Share:

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares are trading higher by $2.94 (8.8 percent) at $39.01 in Monday's session.

After the close on Friday, rumors surfaced that up to four companies may be potential bidders for the company. Those mentioned were AstraZeneca plc (ADR) (NYSE: AZN), Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ: TEVA), Biogen Inc (NASDAQ: BIIB) and Allergan plc Ordinary Shares (NYSE: AGN).

The rumors instigated a higher and after a brief retreat into the upper portion of Friday's range (Friday's high was $36.83) to $36.48, the rally continued in earnest. It has continued to make new highs for the day with the current one standing at $39.13. This marks the highest level for the issue since it peaked on November 30 at $39.41.

 

Related Articles (ACAD)

View Comments and Join the Discussion!

Posted-In: News Rumors Technicals Intraday Update Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com